A macrolactone from benzo[a]phenazine with potent activity against Mycobacterium tuberculosis

被引：21
|
作者：
Silva, Raphael S. F. [1 ]
Pinto, Maria do Carmo F. R. [1 ]
Goulart, Marilia O. F. [2 ]
de Souza Filho, Jose D. [3 ]
Neves, Ivan, Jr. [4 ]
Lourenco, Maria Cristina S. [4 ]
Pinto, Antonio V. [1 ]
机构：
[1] Univ Fed Rio de Janeiro, Ilha Fundao, CCS, Nucleo Pesquisas Prod Nat, BR-21941902 Rio De Janeiro, Brazil
[2] Univ Fed Alagoas, Inst Quim & Biotecnol, BR-57072970 Maceio, AL, Brazil
[3] Univ Fed Minas Gerais, Dept Quim, ICEx, BR-31270901 Belo Horizonte, MG, Brazil
[4] Inst Pesquisa Clin Evandro Chagas, Serv Bacteriol, Setor Testagem Drogas, BR-21045900 Rio De Janeiro, Brazil
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 44卷 / 05期
关键词：
Lapachol; Phenazines; Peracetic acid oxidation; Macrolactones; Tuberculosis; ALAMAR BLUE ASSAY; IN-VITRO ACTIVITY; BETA-LAPACHONE; OXIDATIVE CLEAVAGE; ANTIMYCOBACTERIAL ACTIVITY; DERIVATIVES; PHENAZINES;
D O I：
10.1016/j.ejmech.2008.06.014
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report here an alternative to the MCPBA or ozonolysis-based oxidation methods of quinoxaline-featuring compounds prepared from beta-lapachones. The use of peracetic acid allowed a simple preparation of the corresponding macrolactones by cleavage of the ring system. These lactones were evaluated for their antimycobacterial potential and compound 4 turned out to have an MIC of 0.62 mu g per mL on Mycocabteriumtuberculosis H37Rv. These results justify further research into its value as a potential lead for an original treatment of tuberculosis. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：2334 / 2337
页数：4
相关论文
共 50 条
  • [21] Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis
    Fernandes, Guilherme F. S.
    Campos, Debora L.
    Da Silva, Isabel C.
    Prates, Joao L. B.
    Pavan, Aline R.
    Pavan, Fernando R.
    Dos Santos, Jean L.
    CHEMMEDCHEM, 2021, 16 (08) : 1268 - 1282
  • [22] 1,3-Azoles from ortho-naphthoquinones: Synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis
    Moura, Kelly C. G.
    Carneiro, Paula F.
    Pinto, Maria do Carmo F. R.
    da Silva, Jose A.
    Malta, Valeria R. S.
    de Simone, Carlos A.
    Dias, Gleiston G.
    Jardim, Guilherme A. M.
    Cantos, Jessica
    Coelho, Tatiane S.
    Almeida da Silva, Pedro E.
    da Silva, Eufranio N., Jr.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (21) : 6482 - 6488
  • [23] Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis
    Caleffi-Ferracioli, Katiany R.
    Cardoso, Rosilene F.
    de Souza, Joao V. P.
    Murase, Leticia S.
    Canezin, Pedro H.
    Scodro, Regiane B. L.
    Siqueira, Vera L. D.
    Pavan, Fernando R.
    FUTURE MICROBIOLOGY, 2019, 14 (03) : 185 - 194
  • [24] Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis
    dos Santos Fernandes, Guilherme Felipe
    de Souza, Paula Carolina
    Marino, Leonardo Biancolino
    Chegaev, Konstantin
    Guglielmo, Stefano
    Lazzarato, Loretta
    Fruttero, Roberta
    Chung, Man Chin
    Pavan, Fernando Rogerio
    dos Santos, Jean Leandro
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 : 523 - 531
  • [25] Fidaxomicin has high in vitro activity against Mycobacterium tuberculosis
    Sun, Qing
    Wang, Shuqi
    Liao, Xinlei
    Jiang, Guanglu
    Huang, Hairong
    Li, Hao
    Wang, Guirong
    JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 70 (03)
  • [26] In vitro activity of tubercidin against Mycobacterium tuberculosis and nontuberculosis Mycobacteria
    Sun, Qing
    Liao, Xinlei
    Yan, Jun
    Jiang, Guanglu
    Huo, Fengmin
    Wang, Guirong
    Li, Hao
    JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 72 (11)
  • [27] Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against Mycobacterium tuberculosis
    Hembre, Erik
    Early, Julie V.
    Odingo, Joshua
    Shelton, Catherine
    Anoshchenko, Olena
    Guzman, Junitta
    Flint, Lindsay
    Dennison, Devon
    McNeil, Matthew B.
    Korkegian, Aaron
    Ovechkina, Yulia
    Ornstein, Paul
    Masquelin, Thierry
    Hipskind, Philip A.
    Parish, Tanya
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [28] In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis
    Guo, N.
    Wu, J.
    Fan, J.
    Yuan, P.
    Shi, Q.
    Jin, K.
    Cheng, W.
    Zhao, X.
    Zhang, Y.
    Li, W.
    Tang, X.
    Yu, L.
    LETTERS IN APPLIED MICROBIOLOGY, 2014, 58 (04) : 344 - 349
  • [29] Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH
    de Carvalho, Hayalla Correa
    Ieque, Andressa Lorena
    Valverde, Tamires Leite
    Baldin, Vanessa Pietrowski
    Meneguello, Jean Eduardo
    Zanetti Campanerut-Sa, Paula Aline
    Vandresen, Fabio
    Ghiraldi Lopes, Luciana Dias
    Passos Souza, Mariana Regina
    de Souza Santos, Nathally Claudiane
    Dias Siqueira, Vera Lucia
    Caleffi-Ferracioli, Katiany Rizzieri
    Lima Scodro, Regiane Bertin
    Cardoso, Rosilene Fressatti
    MEDICINAL CHEMISTRY, 2021, 17 (05) : 485 - 492
  • [30] Drug Design and Identification of Potent Leads Against Mycobacterium tuberculosis Thymidine Monophosphate Kinase
    Van Calenbergh, S.
    Pochet, S.
    Munier-Lehmann, H.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (07) : 694 - 705
12345